Learn More
Invitrogen™ LILRA5 Polyclonal Antibody

Description
In direct ELISAs, approximately 30% cross-reactivity with recombinant mouse LILRCI is observed and less than 1% cross-reactivity with recombinant rat LILRC2 is observed. Reconstitute at 0.2 mg/mL in sterile PBS.
Specifications
Specifications
| Antigen | LILRA5 |
| Applications | Western Blot, Immunocytochemistry |
| Classification | Polyclonal |
| Concentration | 0.2 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 5% trehalose and No Preservative |
| Gene | LILRA5 |
| Gene Accession No. | 0 |
| Gene Alias | CD85; CD85 antigen-like family member F; CD85f; CD85f antigen; E030017K20; EG232801; Gm4878; ILT11; ILT-11; Immunoglobulin-like transcript 11; immunoglobulin-like transcript 11 protein; leucocyte Ig-like receptor A5; leukocyte Ig-like receptor 9; leukocyte immunoglobulin like receptor A5; leukocyte immunoglobulin-like receptor; leukocyte immunoglobulin-like receptor 9; Leukocyte immunoglobulin-like receptor subfamily A member 5; leukocyte immunoglobulin-like receptor subfamily A member 5 soluble; leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 7; LILRA5; LILRB7; Lilrc1; LIR9; LIR-9 |
| Gene Symbols | LILRA5 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.